{"id":593462,"date":"2019-11-28T04:16:03","date_gmt":"2019-11-28T04:16:03","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/"},"modified":"2019-11-28T04:16:03","modified_gmt":"2019-11-28T04:16:03","slug":"fra-gives-rameda-green-light-on-public-subscription-notice","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/","title":{"rendered":"FRA gives Rameda green light on public subscription notice"},"content":{"rendered":"<p><a class=\"content-anchor\" id=\"tldr-story-02\"><\/a> <strong>IPO WATCH- Market regulator gives Rameda green light on public subscription <\/strong><strong>notice:<\/strong> The Financial Regulatory Authority (FRA) has approved Rameda Pharma\u2019s <a href=\"https:\/\/ramedapharma.com\/\">public subscription notice (pdf)<\/a> to local investors for its initial public offering on the EGX, according to a <a href=\"https:\/\/www.egx.com.eg\/downloads\/Bulletins\/237335_1.pdf\">statement to the bourse (pdf)<\/a>. Rameda <a href=\"http:\/\/ramedapharma-ir.com\/downloads\/ramedafinalprice.pdf\">has announced (pdf)<\/a> that it will offer 376,606,000 shares at a price of EGP 4.66 per ordinary share in its IPO.<\/p>\n<p><strong>Greville Investing, the selling shareholder, will offer 357,775,700 shares to institutional investors in an international offering<\/strong>, while the remainder are earmarked for retail investors in Egypt. You can find more information in the company\u2019s <a href=\"http:\/\/ramedapharma-ir.com\/downloads\/Rameda_EGX2019-ITF.pdf\">intention to float (pdf) from last month<\/a>.<\/p>\n<p><strong>The subscription period for the transacation\u2019s retail offering is set to begin today<\/strong>, <a href=\"https:\/\/af.reuters.com\/article\/egyptNews\/idAFL8N2871A6\">an unnamed company official tells Reuters<\/a>. <strong>Trading is expected to get underway on 11 December <\/strong>under the ticker RMDA.<\/p>\n<p><strong>Advisors:<\/strong> HSBC and Investec are joint global coordinators and bookrunners for the international offering, while CI Capital is joint bookrunner. Compass Capital is the IPO advisor, and <a href=\"http:\/\/www.inktankcommunications.com\/\">Inktank<\/a> is investor relations advisor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO WATCH- Market regulator gives Rameda green light on public subscription notice: The Financial Regulatory Authority (FRA) has approved Rameda Pharma\u2019s public subscription notice (pdf) to local investors for its initial public offering on the EGX, according to a statement to the bourse (pdf). Rameda has announced (pdf) that it will offer 376,606,000 shares at [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":593463,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[136,998,68,72,76,490,11073,78,449,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-593462","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-speed-round","tag-ci-capital","tag-compass-capital","tag-egx","tag-enterpriseam","tag-financial-regulatory-authority","tag-hsbc","tag-inktank-communications","tag-ipo-watch","tag-rameda-pharma","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"30045e86-01e0-4e12-9595-fe62826b082c","is_powered_by":true,"section_story_id":"0d8c72f4-1648-4347-a729-8b8478ac2d5b","story_type":"1","photo_url":"https:\/\/ent.news\/2020\/1\/626.jpg","photo_position":"above","related_issue":[593455],"teaser":"","voice_url":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FRA gives Rameda green light on public subscription notice - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FRA gives Rameda green light on public subscription notice\" \/>\n<meta property=\"og:description\" content=\"IPO WATCH- Market regulator gives Rameda green light on public subscription notice: The Financial Regulatory Authority (FRA) has approved Rameda Pharma\u2019s public subscription notice (pdf) to local investors for its initial public offering on the EGX, according to a statement to the bourse (pdf). Rameda has announced (pdf) that it will offer 376,606,000 shares at [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-28T04:16:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"FRA gives Rameda green light on public subscription notice\",\"datePublished\":\"2019-11-28T04:16:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/\"},\"wordCount\":179,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1\",\"keywords\":[\"CI Capital\",\"Compass Capital\",\"EGX\",\"EnterpriseAM\",\"Financial Regulatory Authority\",\"HSBC\",\"Inktank Communications\",\"IPO watch\",\"Rameda Pharma\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/\",\"name\":\"FRA gives Rameda green light on public subscription notice - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1\",\"datePublished\":\"2019-11-28T04:16:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FRA gives Rameda green light on public subscription notice\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FRA gives Rameda green light on public subscription notice - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/","og_locale":"en_US","og_type":"article","og_title":"FRA gives Rameda green light on public subscription notice","og_description":"IPO WATCH- Market regulator gives Rameda green light on public subscription notice: The Financial Regulatory Authority (FRA) has approved Rameda Pharma\u2019s public subscription notice (pdf) to local investors for its initial public offering on the EGX, according to a statement to the bourse (pdf). Rameda has announced (pdf) that it will offer 376,606,000 shares at [&hellip;]","og_url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2019-11-28T04:16:03+00:00","og_image":[{"url":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"FRA gives Rameda green light on public subscription notice","datePublished":"2019-11-28T04:16:03+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/"},"wordCount":179,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1","keywords":["CI Capital","Compass Capital","EGX","EnterpriseAM","Financial Regulatory Authority","HSBC","Inktank Communications","IPO watch","Rameda Pharma","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/","url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/","name":"FRA gives Rameda green light on public subscription notice - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1","datePublished":"2019-11-28T04:16:03+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#primaryimage","url":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1","contentUrl":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"FRA gives Rameda green light on public subscription notice"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?resize=600%2C400&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?resize=600%2C600&ssl=1","author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":593412,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/","url_meta":{"origin":593462,"position":0},"title":"Rameda prices its IPO at EGP 4.66 per share","author":"enterpriseam admin","date":"27 November 2019","format":false,"excerpt":"IPO WATCH- Rameda has priced its IPO at EGP 4.66 per share: Rameda Pharma has announced (pdf) that it will offer 376,606,000 shares at a price of EGP 4.66 per ordinary share in an initial public offering on the EGX. The Arabic-language public subscription notice (PSN) to local investors is\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":593231,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/21\/rameda-receives-greenlight-for-ipo-this-year\/","url_meta":{"origin":593462,"position":1},"title":"Rameda receives greenlight for IPO this year","author":"enterpriseam admin","date":"21 November 2019","format":false,"excerpt":"IPO WATCH- Rameda gets nod for share listing, will go public before the end of the year \u2013FRA: Rameda Pharma has received approval from the Financial Regulatory Authority (FRA) to go public on the EGX before the end of this year, FRA boss Mohamed Omran said at a press conference\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2019\/8\/EGX-1600px.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":591230,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/01\/rameda-pharma-retail-offering-oversubscribed-on-first-day\/","url_meta":{"origin":593462,"position":2},"title":"Rameda Pharma retail offering oversubscribed on first day","author":"enterpriseam admin","date":"1 December 2019","format":false,"excerpt":"IPO WATCH- Rameda Pharma retail offering oversubscribed on first day: The retail component of Rameda\u2019s IPO was oversubscribed at the close of play on Thursday, market sources told the local press. Retail investors put in orders for 19.65 mn shares, handily covering the 18.83 mn shares offered by the pharma\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":591422,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/05\/rameda-pharma-retail-subscription-surges-on-final-day-offering-closes-33x-oversubscribed\/","url_meta":{"origin":593462,"position":3},"title":"Rameda Pharma retail subscription surges on final day, offering closes 33x oversubscribed","author":"enterpriseam admin","date":"5 December 2019","format":false,"excerpt":"Retail appetite for Rameda\u2019s IPO surgest on last day; offering closing 36.3x oversubscribed: Retail investors poured into Rameda Pharma\u2019s 5% public offering on the final day of subscription yesterday, leading the retail component to close 36.3x oversubscribed, Al Mal reports. Investors had placed orders for 683.22 mn shares by the\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":591282,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/02\/rameda-retail-offering-1-6x-oversubscribed-on-second-day-of-subscription\/","url_meta":{"origin":593462,"position":4},"title":"Rameda retail offering 1.6x oversubscribed on second day of subscription","author":"enterpriseam admin","date":"2 December 2019","format":false,"excerpt":"IPO WATCH- Rameda retail offering 1.6x oversubscribed on second day of subscription: Rameda Pharma\u2019s retail offering was 1.6x oversubscribed at the end of the second day of subscription yesterday, according to the local press. Retail investors bid for 29.96 mn shares from a total 18.83 mn shares on offer. The\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":594494,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/","url_meta":{"origin":593462,"position":5},"title":"Rameda announces intention to IPO in 4Q2019","author":"enterpriseam admin","date":"31 October 2019","format":false,"excerpt":"IPO WATCH- Rameda announces intention to IPO in 4Q2019: Rameda Pharma, the country\u2019s fastest-growing generic pharmaceuticals player, announced yesterday morning its intention to sell an undisclosed number of shares in an initial public offering on the EGX in 4Q2019. The company is planning an offering to institutional and international investors\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/593462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=593462"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/593462\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/593455"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media\/593463"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=593462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=593462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=593462"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=593462"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=593462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}